NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

New Mayo study questions value of lung cancer CT scans

Posted By


The screen-at-all-costs mentality takes an intellectual hit with the publication of a new study in the Journal of the American Medical Association. The conclusions of those authors: “Screening for lung cancer with low-dose CT may increase the rate of lung cancer diagnosis and treatment, but may not meaningfully reduce the risk of advanced lung cancer or death from lung cancer. Until more conclusive data are available, asymptomatic individuals should not be screened outside of clinical research studies that have a reasonable likelihood of further clarifying the potential benefits and risks.”

Back in October, another study claimed quite the opposite, and many journalists failed to report with balance on those findings. (See summary on 8 stories on One journalist on the listserv of the Association of Health Care Journalists (AHCJ) has already pointed out this morning that some news organizations will have difficulty explaining the apparent flip-flopping findings today – if they did a naive job in October. Mike Taibbi of NBC News even went on the air in the fall reporting on his own CT scan after a life of smoking, and ended with a personal endorsement of the procedure. No spots on his lungs but now egg on his face.

One who wouldn’t have a tough time explaining the latest study is former Miami Herald reporter Jacob Goldstein, who was recognized on for his excellent story in October. We’ve just learned that his excellence led the Wall Street Journal to lure him away as their first health news blogger.

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.